FDA Reviewing Information on Fosamax-Related Fractures


In a follow-up piece to Monday evening’s report on femur fractures related to Fosamax (alendronate), ABC World News (3/9, story 4, 2:20, Sawyer) reported that ABC’s Richard Besser, MD, interviewed FDA Deputy Commissioner Joshua Sharfstein, MD, asking him if now is the time for the agency “to send out a notice to physicians to be on the lookout for this” problem.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robert Kraft, Kraft & Associates | Attorney Advertising

Written by:


Kraft & Associates on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.